Two new cancer cell line databases bursting with genomic and drug profiling data may help researchers identify drug targets.
Covering the life sciences inside and out
Two new cancer cell line databases bursting with genomic and drug profiling data may help researchers identify drug targets.
A roundup of recent research announced last weekend at the annual conference of the American Association for the Advancement of Science (AAAS).
Researchers develop a tiny device that motors around the stomach, fueled by its acidic environment.
Starvation paired with cancer drugs slowed or stopped unchecked cell growth in yeast and mouse models of cancer, outpacing or matching the isolated effects of chemo.
A single mutant cell breaks free of its neighbors in the early stages of cancer development.
Whole brain radiation therapy costs mice some of their cognitive abilities, but treatment with low-oxygen air revives their reasoning skills.
Certain skin-residing immune cells may—under specific conditions—play a direct role in initiating skin cancer after exposure to environmental toxins.
A new study shows that breast cancers that become resistant to hormone therapy have different patterns of estrogen receptor binding.
Prognostic signatures have become popular tools in cancer research, but it turns out signatures made of random genes are prognostic as well.